NIKKI HELTON: Open Payments
NPI 1821553371 · CLINTWOOD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $120 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| Lundbeck LLC | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: FANAPT, CAPLYTA, REXULTI, INGREZZA, INVEGA SUSTENNA, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
